Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • THERAVANCE INC Financial Overview

  • Income Statement: THRX

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 23.10 M 22.00 M 1.09 M 4.74%
    Gross Profit 16.13 M 22.00 M -5.87 M -36.37%
    Net Income Before Extra Items/Preferred Div -93.64 M -160.00 M 66.35 M -70.86%
    Operating Income -87.78 M -168.56 M 80.78 M -92.02%
  • Cash Flow: THRX

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 173.12 M 7.82 M 165.30 M 95.48%
    Net Cash Flow - Investing 67.37 M -110.59 M 177.96 M 264.17%
    Net Cash Flow/Operating Activities -99.91 M -104.37 M 4.46 M -4.46%
  • Balance Sheet: THRX

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 236.16 M 161.98 M 74.17 M 31.41%
    Total Liabilities 371.10 M 228.25 M 142.86 M 38.50%
    Shareholders Equity -134.95 M -66.26 M -68.68 M 50.90%
  • Key Ratios / Statistics: THRX

    • Valuation

      Price/Earnings (TTM) -8.10
      Price/Sales (TTM) 32.93
      Price/Book (MRQ) -5.80
      Price/Cash Flow (TTM) -17.32
    • Profitability

      Gross Margin 69.86
      Operating Margin -380.09
      Profit Margin -405.45
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 4.58
      Current Ratio (MRQ) 9.43
      Long Term Debt-to-Equity (MRQ) -98.45
    • Management Effectiveness

      Return on Equity (TTM) -260.33
      Return on Assets (TTM) -34.23
      Return on Investments (TTM) -264.25